DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Prism Medico & Pharmacy Ltd (PRISMMEDI) share price today?

Prism Medico & Pharmacy Ltd (PRISMMEDI) is trading at ₹32.88 on the BSE, down 3.27% on the day. Source: DocStoX.

What is the PE ratio of Prism Medico & Pharmacy Ltd?

Prism Medico & Pharmacy Ltd has a price-to-earnings (PE) ratio of 62.0 in the Financial Services sector.

What is the market capitalisation of Prism Medico & Pharmacy Ltd?

Prism Medico & Pharmacy Ltd has a market capitalisation of approximately ₹20 crore.

Is Prism Medico & Pharmacy Ltd a profitable company?

Prism Medico & Pharmacy Ltd generates a return on equity of 2.1% with a net profit margin of 13.0%. That is a modest return on shareholder capital.

What is the 52-week high and low of PRISMMEDI?

Prism Medico & Pharmacy Ltd (PRISMMEDI) has traded between ₹15.51 and ₹34.65 over the past 52 weeks, against a current price of ₹32.88.

Prism Medico & Pharmacy Ltd

₹32.88▼ -1.11 (-3.27%)

PRISMMEDI·BSE·Financial Services

Market Cap

19.71 Cr

PE Ratio

62.04

Volume

41,659

Day High - Low

34.65 - 31.01

52W High-Low

34.65 - 15.51

₹32.88▼ -1.11 (-3.27%)

Market Cap19.71 Cr

PE Ratio62.04

Volume41,659

Day High - Low34.65 - 31.01

52W High-Low34.65 - 15.51

Prism Medico & Pharmacy Ltd (PRISMMEDI): company summary

Annual revenue rose 287.3% to ₹2 crore, but the latest quarter revenue fell 100.0% to ₹0 crore compared to ₹2 crore a year earlier.

Prism Medico & Pharmacy Ltd (PRISMMEDI) is a micro-cap Financial Services company valued at ₹20 crore operating in NBFC on the NSE and BSE.

Recent price move: Prism Medico & Pharmacy Ltd last traded at ₹32.88, down 3.27% on the day.
Recent developments: On 2026-06-30, the company reported a net profit loss of ₹0 crore for the latest quarter, reversing from a profit of ₹1 crore in the same quarter a year earlier. On 2026-03-31, the company's promoter holding increased by 4.49 percentage points to 29.98%.
Financial performance: Annual revenue rose 287.3% to ₹2 crore, but the latest quarter revenue fell 100.0% to ₹0 crore compared to ₹2 crore a year earlier. Net profit swung from a net loss of ₹0 crore to a profit of ₹0 crore annually, while the latest quarter net profit turned from a profit of ₹1 crore to a loss of ₹0 crore. The net profit margin improved 20.7 percentage points to 13.0%.
Valuation multiples: The stock trades at 62.0 times earnings, a premium to the Financial Services median of 19.3, 1.76 times book value.
Things to watch: The latest quarter net profit turned from a profit of ₹1 crore to a loss of ₹0 crore. The latest quarter revenue fell 100.0% to ₹0 crore compared to ₹2 crore a year earlier. The company's net profit margin, though improved, remains at 13.0%.
Where it stands: The company's latest quarter revenue fell 100.0% to ₹0 crore, while annual revenue rose 287.3% to ₹2 crore. The latest quarter net profit turned from a profit of ₹1 crore to a loss of ₹0 crore. The net profit margin improved 20.7 percentage points to 13.0%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

3.6/10

Poor

Fair Value

ROE

2.07%

Weak

P/E

62.04x

Expensive

Debt / Equity

0.00

Low

Industry

Financial Services

NBFC

Overall View

Mixed

Price performance

Day₹31.01

₹34.65

52W₹15.51

₹34.65

DocStoX take

Supported by momentum (7.5), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 2.4. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence

3.6

/10

Poor

Quality

Weak

ROE 2.1%

Valuation

Expensive

P/E 62.0×

Growth

No data

No multi-year history

Risk

Moderate

D/E 0.00 (lender)

Momentum

Strong

91% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹33

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹20 Cr

52W High / Low

₹35 / ₹16

Dividend Yield

0.00%

Promoter Holding

29.98%

EPS (TTM)

₹0.53

Book Value

₹25.42

Key highlights

Loss-making in some of the last 5 years
Quality is weak (2.4/10)

0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Financial Services stocks · NBFC

Explore Prism Medico & Pharmacy Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Prism Medico & Pharmacy Ltd peers in Financial Services

Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.

HDFC Bank Limited ICICI Bank Limited State Bank of India Bajaj Finance Limited Life Insurance Corporation Of India Kotak Mahindra Bank Limited Axis Bank Limited Bajaj Finserv Limited Shriram Finance Limited SBI Life Insurance Company Limited Jio Financial Services Limited Punjab National Bank

Compare Prism Medico & Pharmacy Ltd with peers

Prism Medico & Pharmacy Ltd vs HDFC Bank Limited Prism Medico & Pharmacy Ltd vs ICICI Bank Limited Prism Medico & Pharmacy Ltd vs State Bank of India Prism Medico & Pharmacy Ltd vs Bajaj Finance Limited Prism Medico & Pharmacy Ltd vs Life Insurance Corporation Of India Prism Medico & Pharmacy Ltd vs Kotak Mahindra Bank Limited

Related tools & concepts

Value Prism Medico & Pharmacy Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

PRISMMEDI newsLatest coverage & filings Open screenerFilter the whole market